Dear Ms. Mathis:
 
Thanks for the rapid reply. I stand corrected and will post your email on my blog.
 
Regards,
Michael Petrelis
 
 
In a message dated 3/14/2005 12:36:32 PM Pacific Standard Time, mathis@nytimes.com writes:
Dear Mr. Petrelis,
      The initial article on David Ho's defensin discovery, in Sept. 2002,
      noted that Ciphergen and Aaron Diamond would be applying for patents
      on the discovery, with royalties going to Aaron Diamond. The point of
      the 2004 article  was that the previous conclusions about defensins
      were wrong. The issue of patents was simply irrelevant, and in any
      case, those patents were presumably rendered worthless.
      Sincerely,
      Catherine Mathis
      VP, Corporate Communications
      The New York Times Company
      212-556-1981 (office)
      917-593-7425 (cell)
      mathis@nytimes.com
No comments:
Post a Comment